A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

863

Participants

Timeline

Start Date

November 25, 2014

Primary Completion Date

July 27, 2016

Study Completion Date

July 27, 2016

Conditions
Urgency IncontinenceUrinary Bladder OveractiveOveractive BladderUrologic DiseasesUrinary Bladder Diseases
Interventions
DRUG

Betmiga®

Oral

Trial Locations (60)

7440

Site DK45004 Regionshospitalet Herning, Herning

9900

Site DK45003 Sygehus Vendsyssel, Frederikshavn, Frederikshavn

11527

Site GR30009 PGH Laiko, Athens

11528

"Site GR30001 General Hospital of Athens Alexandra", Athens

20014

Site ES34021 H. de Donostia, Donostia / San Sebastian

20850

Site ES34012 H. de Mendaro, Mendaro

26504

Site GR30003 University Hospital of Patras, Pátrai

27003

Site ES34019 Hospital Universitario Lucus Augusti, Lugo

36211

Site ES34010 Policlínico de Vigo, S.A.-POVISA, Vigo

41110

Site GR30005 University Hospital of Larissa, Larissa

45445

Site GR30008 University Hospital of Ioannina, Ioannina

45500

Site GR30013 University Hospital of Ioannina, Ioannina

47011

Site ES34011 Hospital del Rio Hortega, Valladolid

48013

Site ES34020 Hospital Universitario Basurto, Bilbao

56403

Site GR30006 Papageorgiou General Hospital, Thessaloniki

Site GR30012 Papageorgiou General Hospital of Thessaloniki, Thessaloniki

71110

Site GR30002 University Hospital of Crete, Heraklion

71409

Site GR30011 General Hospital of Heraklion 'Venizelio-Pananio', Heraklion

615 00

Site CZ42009 UROMEDA s. r. o., Brno

Unknown

Site CZ42003 Fakultni nemocnice Brno-Bohunice, Brno

Site CZ42006 Hospital Kyjov, Kyjov

Site CZ42002 Fakultni nemocnice Kralovske Vinohrady, Prague

Site CZ42007 MEDICON a.s., Prague

Site CZ42008 Oblastni nemocnice Pribram, Příbram

Site CZ42004 Krajská nemocnice Tomáše Bati, Zlín

Site IE35304 Midland Regional Hospital, Mullingar

Site IE35302 Coombe Hospital, Dublin

Site IE35303 Kerry General Hospital, Kerry

Site SK42107 Private Urological Care Center, Trenčín

Site ES34017 Hospital de Mollet, Barcelona

151 26

Site GR30007 Sismanoglio General Hospital, Athens

833 05

Site SK42101 Univerzitná nemocnica Bratislava - Kramáre, Bratislava

934 01,

Site SK42106 UROCENTRUM LEVICE, s.r.o., Levice

03101

Site SK42102 UROAMB, s.r.o., Liptovský Mikuláš

979 01

Site SK42104 Urologicka ambulancia, Miramed, sro, Rimavská Sobota

093 01

Site SK42103 CMFF, sro, Vranov nad Topľou

965 63

Site SK42105 ProCare Ziar nad Hronom, Žiar nad Hronom

08208

Site ES34005 Corporació Sanitaria Parc Taulí, Sabadell

08022

Site ES34015 Centro Médico Teknon, Barcelona

08035

Site ES34007 Hospital Universitario Vall D'Hebron, Barcelona

09200

Site ES34009 Hospital Comarcal Santiago Apostol, Burgos

412 55

Site SE46002 Urologkliniken Carlanderska, Gothenburg

BD9 6RJ

Site GB44005 Bradford Royal Infirmary, Bradford

BB10 2PQ

Site GB44011 Royal Blackburn Hospital, Burnley

CB2 0QQ

Site GB44016 Addenbrookes Hospital, Cambridge

PO19 6SE

Site GB44009 St. Richards Hospital, Chichester

NN1 5BD

Site GB44007 Northampton General Hospital, Cliftonville

CV2 2DX

Site GB44015 University Hospital Coventry, Coventry

CR7 7YE

Site GB44008 Croydon University Hospital, Croydon

PL6 8DH

Site GB44003 Derriford Hospital, Derriford

EX31 4JB

Site GB44019 Northern Devon Healthcare, Devon

ME5 7NY

Site GB44001 Medway Hospital, Gillingham

G51 4TF

Site GB44004 Southern General Hospital, Glasgow

PE29 6NT

Site GB44013 Hinchingbrooke Hospital, Huntingdon

NE7 7DN

Site GB44010 The Freeman Hospital, Newcastle upon Tyne

PE30 4ET

Site GB44014 The Queen Elizabeth Hospital King's Lynn NHS Trust, Norfolk

RG1 5AN

Site GB44002 The Royal Berkshire Hospital, Reading

SP2 8BJ

Site GB44018 Salisbury District Hospital, Salisbury

SR4 7TP

Site GB44017 Sunderland Royal University Hospital, Sunderland

WV10 OQP

Site GB44006 New Cross Hospital, Wolverhampton

All Listed Sponsors
lead

Astellas Pharma Europe Ltd.

INDUSTRY

NCT02320773 - A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice | Biotech Hunter | Biotech Hunter